Accutane iPLEDGE Debut On Track Despite Calls For Delay
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA confirmed that it would not delay the March 1 implementation of the isotretinoin risk management program.
You may also be interested in...
FDA Harnesses Search Engine Power To Warn Of Risks Of Buying Accutane Online
Web page is designed to warn consumers of risks of isotretinoin when they search online for Accutane or a generic version.
FDA Harnesses Search Engine Power To Warn Of Risks Of Buying Accutane Online
Web page is designed to warn consumers of risks of isotretinoin when they search online for Accutane or a generic version.
Accutane Risk Management Program Loosens Restrictions
Males and females of non-child bearing potential – over half the iPLEDGE participants – can now fill their scripts even if they miss the seven-day window.